In Vitro and In Vivo Diagnostic Substances - Investment Trends

This page shows the overall investment trends by institutions in companies categorized in this industry.

To create this report, we combined institutional holdings listed in 13F's with SIC codes self-reported by companies in their 10-Q's.

Period Owners Total Shares Percent Change
in Shares
Fair Market Value (USD) Percent Change
in Value
2025-Q2 1,600 836,752,596 0.06 51,024,808,403,000 16.30
2025-Q1 1,559 836,288,646 1.38 43,873,470,614,000 -2.62
2024-Q4 1,541 824,881,768 4.26 45,051,910,400,000 -18.26
2024-Q3 1,537 791,146,455 0.80 55,116,218,209,000 4.38
2024-Q2 1,515 784,870,666 2.44 52,802,580,278,000 -4.75
2024-Q1 1,540 766,197,114 1.96 55,434,091,728,000 -5.21
2023-Q4 1,572 751,456,815 8.30 58,482,106,868,000 19.00
2023-Q3 1,464 693,844,015 -10.85 49,144,071,929,000 -13.05
2023-Q2 1,515 778,259,343 2.42 56,517,844,420,000 1.22
2023-Q1 1,519 759,848,506 -5.00 55,839,059,587,000 23.91
2022-Q4 1,513 799,830,569 -8.40 45,064,544,805,000 3,529.00
2022-Q3 1,434 873,166,253 10.76 1,241,790,300,000 25.64
2022-Q2 1,406 788,376,042 -19.65 988,380,429,000 -29.68
2022-Q1 1,517 981,188,782 -0.05 1,405,495,949,000 88.43
2021-Q4 1,598 981,720,561 1.29 745,912,472,000 -4.62
2021-Q3 1,484 969,249,472 0.23 782,026,014,000 -3.65
2021-Q2 1,476 967,025,412 7.06 811,638,650,000 29.65
2021-Q1 1,401 903,227,439 42.19 626,001,100,000 1.53
2020-Q4 1,366 635,246,496 -23.46 616,585,210,000 0.48
2020-Q3 1,337 830,006,762 1.66 613,661,078,000 37.00
2020-Q2 1,226 816,456,891 15.53 447,940,636,000 -8.07
2020-Q1 1,112 706,721,074 -0.24 487,237,157,000 41.62
2019-Q4 1,128 708,416,301 4.88 344,040,376,000 43.97
2019-Q3 1,067 675,480,929 -1.25 238,967,334,000 1.88
2019-Q2 1,080 684,012,312 1.19 234,565,363,000 12.02
2019-Q1 1,093 675,954,929 -4.45 209,404,399,000 15.14
2018-Q4 1,083 707,408,399 0.99 181,869,209,000 -24.04
2018-Q3 1,107 700,467,598 0.85 239,426,061,000 20.03
2018-Q2 1,072 694,568,918 -0.54 199,479,514,000 -15.82
2018-Q1 1,053 698,346,298 1.68 236,978,012,000 26.46
2017-Q4 1,003 686,774,838 -8.06 187,396,709,000 -38.80
2017-Q3 996 747,021,184 5.83 306,185,315,000 72.78
2017-Q2 1,006 705,867,456 4.33 177,212,984,000 -50.36
2017-Q1 974 676,547,250 1.46 356,968,167,000 4.95
2016-Q4 961 666,823,942 6.53 340,139,073,000 -9.32
2016-Q3 891 625,969,898 -2.67 375,085,222,000 -10.93
2016-Q2 865 643,167,005 -3.57 421,108,656,000 -17.89
2016-Q1 819 666,961,191 -1.07 512,852,803,000 41.20
2015-Q4 809 674,184,233 -0.80 363,202,750,000 4.43
2015-Q3 816 679,603,222 -1.21 347,810,401,000 -0.52
2015-Q2 843 687,926,498 11.00 349,613,041,000 5.29
2015-Q1 848 619,729,427 0.00 332,057,696,000 0.00